Choice of Hypomethylating Agent (HMA) for Initial Treatment Does Not Influence Outcome or Survival for Therapy-Related Myeloid Neoplasms (T-Mn)Charlene C. Kabel,Debra A. Goldman,Larry W. Buie,Virginia M. KlimekBlood(2019)引用 1|浏览21暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要